Cargando…
Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extract
Compound K is a major metabolite of ginsenoside Rb1, which has various pharmacological activities in vivo and in vitro. However, previous studies have focused on the pharmacokinetics of a single metabolite or the parent compound and have not described the pharmacokinetics of both compounds in humans...
Autor principal: | Kim, Hyung-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Ginseng
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825860/ https://www.ncbi.nlm.nih.gov/pubmed/24235859 http://dx.doi.org/10.5142/jgr.2013.37.451 |
Ejemplares similares
-
Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings
por: Choi, Min-Koo, et al.
Publicado: (2020) -
Pharmacokinetics of Ginsenoside Rb1, Rg3, Rk1, Rg5, F2, and Compound K from Red Ginseng Extract in Healthy Korean Volunteers
por: Kim, Hyung Joong, et al.
Publicado: (2022) -
The skin protective effects of compound K, a metabolite of ginsenoside Rb1 from Panax ginseng
por: Kim, Eunji, et al.
Publicado: (2018) -
Korean Red Ginseng Saponin Fraction Rich in Ginsenoside-Rb1, Rc and Rb2 Attenuates the Severity of Mouse Collagen-Induced Arthritis
por: Endale, Mehari, et al.
Publicado: (2014) -
Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice
por: Yoo, Yung Choon, et al.
Publicado: (2013)